SARS-CoV-2 Vaccination: Long-Term Follow-Up of Pre-existing and De Novo Immune Thrombocytopenia

Thromb Haemost. 2023 Apr;123(4):482-486. doi: 10.1055/a-2002-1931. Epub 2022 Dec 20.

Authors

Marina Beltrami Moreira¹, James B Bussel^{1

2}, Eun Ju Lee¹

Affiliations

¹ Division of Hematology and Medical Oncology, New York Presbyterian Hospital - Weill Cornell Medicine, New York, New York, United States.
² Division of Pediatric Hematology/Oncology, New York Presbyterian Hospital - Weill Cornell, New York, New York, United States.

PMID: 36539200
DOI: 10.1055/a-2002-1931

No abstract available

MeSH terms

COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Follow-Up Studies
Humans
Purpura, Thrombocytopenic, Idiopathic*
SARS-CoV-2
Thrombocytopenia*
Vaccination

Substances

COVID-19 Vaccines